Erratum: Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability

Authors

Publication Details

Journal
Journal of Thoracic Disease
Published
2025-12-01
DOI
https://doi.org/10.21037/jtd-2025b-14
Primary Topic
Angiogenesis and VEGF in Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Erratum: Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability

Editorial Office
Journal of Thoracic Disease
Angiogenesis and VEGF in Cancer
article

Erratum: Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability

Editorial Office
article en

Abstract

No abstract available for this paper.
Journal of Thoracic DiseaseVol. 17(12)
Good health and well-being
Openalex Percentile: Top 35%
Angiogenesis and VEGF in Cancer
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Erratum: Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability — Editorial Office · Journal of Thoracic Disease (2025) | TGRS Research Map | TGRS